Moderna and Global Partners Secure $60 Million to Accelerate Ebola Vaccine Development

Biotechnology giant Moderna has announced new funding commitments to fast-track its Ebola vaccine candidate through advanced clinical trials, marking a significant escalation in the global race to combat one of Africa’s deadliest viral hemorrhagic fevers. The Deal The funding package includes partnerships with international health organizations, and government health agencies. The vaccine utilizes Moderna’s mRNA […]